Lessons Learned Through Adaptation of a Model Successful during the COVID Pandemic: Expanding HIV Self-testing for Persons Who Use Drugs.

IF 4.2 3区医学 Q1 SUBSTANCE ABUSE Journal of Addiction Medicine Pub Date : 2024-12-12 DOI:10.1097/ADM.0000000000001432

Alicia Huerta, Ella Salim, Haley V Bonilla, Sarah E Miller, Sabrina A Assoumou

{"title":"Lessons Learned Through Adaptation of a Model Successful during the COVID Pandemic: Expanding HIV Self-testing for Persons Who Use Drugs.","authors":"Alicia Huerta, Ella Salim, Haley V Bonilla, Sarah E Miller, Sabrina A Assoumou","doi":"10.1097/ADM.0000000000001432","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>The US overdose crisis is driving a surge in HIV diagnoses among persons who inject drugs (PWID). Innovative approaches are needed to address this increase in cases. Although HIV self-testing (HIVST) was hailed as a potential \"game-changer\" upon initial approval by the Food and Drug Administration over a decade ago, this convenient testing modality has not reached its full potential to impact the HIV epidemic. Nevertheless, lessons regarding self-testing for infectious diseases from the COVID-19 pandemic present an opportunity to increase HIVST uptake and reach current US goals of Ending the HIV Epidemic (EHE) by 2030. In this commentary, we first discuss facilitators and barriers of HIVST for PWID. We then explore how lessons regarding self-testing during the COVID-19 pandemic can allow us to realize the potential of HIVST for PWID. We conclude by suggesting the future utilization of HIVST to address 2 EHE pillars, rapid diagnosis of HIV cases and cluster identification.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001432","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract: The US overdose crisis is driving a surge in HIV diagnoses among persons who inject drugs (PWID). Innovative approaches are needed to address this increase in cases. Although HIV self-testing (HIVST) was hailed as a potential "game-changer" upon initial approval by the Food and Drug Administration over a decade ago, this convenient testing modality has not reached its full potential to impact the HIV epidemic. Nevertheless, lessons regarding self-testing for infectious diseases from the COVID-19 pandemic present an opportunity to increase HIVST uptake and reach current US goals of Ending the HIV Epidemic (EHE) by 2030. In this commentary, we first discuss facilitators and barriers of HIVST for PWID. We then explore how lessons regarding self-testing during the COVID-19 pandemic can allow us to realize the potential of HIVST for PWID. We conclude by suggesting the future utilization of HIVST to address 2 EHE pillars, rapid diagnosis of HIV cases and cluster identification.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

通过适应在COVID大流行期间取得成功的模式吸取的教训：扩大吸毒者的艾滋病毒自我检测。

摘要：美国药物过量危机正在推动注射吸毒者（PWID）中HIV诊断的激增。需要采取创新办法来解决案件增加的问题。尽管艾滋病毒自我检测（HIVST）在十多年前获得美国食品和药物管理局（Food and Drug Administration）的初步批准时被誉为潜在的“游戏规则改变者”，但这种便捷的检测方式尚未充分发挥其影响艾滋病毒流行的潜力。尽管如此，从2019冠状病毒病大流行中获得的关于传染病自我检测的经验教训为提高艾滋病毒感染者的感染率和实现美国目前到2030年结束艾滋病毒流行（EHE）的目标提供了机会。在这篇评论中，我们首先讨论艾滋病毒传播对PWID的促进因素和障碍。然后，我们探讨了在COVID-19大流行期间关于自我检测的经验教训如何使我们能够实现艾滋病毒传播对PWID的潜力。最后，我们建议未来利用HIV来解决2个EHE支柱，快速诊断HIV病例和集群识别。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Addiction Medicine 医学-药物滥用

CiteScore

6.10

自引率

9.10%

发文量

260

审稿时长

>12 weeks

期刊介绍： The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including: •addiction and substance use in pregnancy •adolescent addiction and at-risk use •the drug-exposed neonate •pharmacology •all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances •diagnosis •neuroimaging techniques •treatment of special populations •treatment, early intervention and prevention of alcohol and drug use disorders •methodological issues in addiction research •pain and addiction, prescription drug use disorder •co-occurring addiction, medical and psychiatric disorders •pathological gambling disorder, sexual and other behavioral addictions •pathophysiology of addiction •behavioral and pharmacological treatments •issues in graduate medical education •recovery •health services delivery •ethical, legal and liability issues in addiction medicine practice •drug testing •self- and mutual-help.